FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128713380> ?p ?o ?g. }

• W3128713380 abstract "Abstract Background Cirrhosis-associated portal vein thrombosis (CA-PVT) has been reportedly observed in 5–30% of cirrhotic patients. Moreover, the acute exacerbation of CA-PVT is likely to occur after certain situations, such as a status after abdominal surgery. Safety and efficacy of the direct-acting oral anticoagulant (DOAC) used for cirrhotic patients have been being confirmed. However, use of the DOAC as an initial treatment for CA-PVT appears still challenging especially in the early postoperative period after major surgery in terms of unestablished efficacy and safety in such occasion. Case presentation We herein report a case of the acute exacerbation of CA-PVT in the early postoperative period after abdominal surgery, which was successfully treated with DOAC, edoxaban used as an initial treatment. The patient was a 79-year-old Japanese male with alcoholic cirrhosis. The patient suffered choledocholithiasis and had a mural chronic CA-PVT extending from the superior mesenteric vein to the portal trunk. He underwent open cholecystectomy and choledochotomy. Early postoperative clinical course was uneventful except for abdominal distension due to ascites diagnosed on postoperative day (POD)7 when hospital discharge was planned. Contrast enhancement computed tomography (CE-CT) taken on POD 7 revealed the exacerbation of the CA-PVT. Despite recommendation for extension of hospital admission with low molecular weight heparin treatment, the patient strongly hoped to be discharged. Unwillingly, we selected DOAC, edoxaban, as an initial treatment, which was commenced the day after discharge (POD8). As a result, the remarkable improvement of the exacerbated CA-PVT was confirmed by the CE-CT taken on POD21. Any bleeding complications were not observed. Although a slight residue of the CA-PVT remains, the patient is currently doing well 4 years after surgery and is still receiving edoxaban. Any adverse effects of edoxaban have not been observed for 4 years. Conclusions A case of successful treatment of the acute exacerbation of CA-PVT with edoxaban was reported. Moreover, edoxaban has been safely administered in a cirrhotic patient for 4 years. The findings obtained from the present case suggest that DOAC can be used as an initial treatment for CA-PVT even in early postoperative period after major abdominal surgery." @default.
• W3128713380 created "2021-02-15" @default.
• W3128713380 creator A5000085626 @default.
• W3128713380 creator A5001659211 @default.
• W3128713380 creator A5020530683 @default.
• W3128713380 creator A5040677118 @default.
• W3128713380 creator A5043460153 @default.
• W3128713380 creator A5062043803 @default.
• W3128713380 creator A5074813969 @default.
• W3128713380 creator A5076935419 @default.
• W3128713380 creator A5086960964 @default.
• W3128713380 creator A5091806809 @default.
• W3128713380 date "2021-02-10" @default.
• W3128713380 modified "2023-09-23" @default.
• W3128713380 title "Treatment of acute exacerbation of liver-cirrhosis-associated portal vein thrombosis with direct-acting oral anticoagulant, edoxaban, used as an initial treatment in the early postoperative period after abdominal surgery: a case report" @default.
• W3128713380 cites W1480212256 @default.
• W3128713380 cites W1528561544 @default.
• W3128713380 cites W1641613989 @default.
• W3128713380 cites W1897345853 @default.
• W3128713380 cites W2010968851 @default.
• W3128713380 cites W2027735039 @default.
• W3128713380 cites W2049078086 @default.
• W3128713380 cites W2051770562 @default.
• W3128713380 cites W2080490516 @default.
• W3128713380 cites W2092398030 @default.
• W3128713380 cites W2097256068 @default.
• W3128713380 cites W2115273341 @default.
• W3128713380 cites W2160625453 @default.
• W3128713380 cites W2211816300 @default.
• W3128713380 cites W2416980505 @default.
• W3128713380 cites W2524160093 @default.
• W3128713380 cites W2553111370 @default.
• W3128713380 cites W2603502286 @default.
• W3128713380 cites W2766403890 @default.
• W3128713380 cites W2771087973 @default.
• W3128713380 cites W2810663607 @default.
• W3128713380 cites W2938919424 @default.
• W3128713380 doi "https://doi.org/10.1186/s13256-020-02651-y" @default.
• W3128713380 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7874483" @default.
• W3128713380 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33563326" @default.
• W3128713380 hasPublicationYear "2021" @default.
• W3128713380 type Work @default.
• W3128713380 sameAs 3128713380 @default.
• W3128713380 citedByCount "1" @default.
• W3128713380 countsByYear W31287133802021 @default.
• W3128713380 crossrefType "journal-article" @default.
• W3128713380 hasAuthorship W3128713380A5000085626 @default.
• W3128713380 hasAuthorship W3128713380A5001659211 @default.
• W3128713380 hasAuthorship W3128713380A5020530683 @default.
• W3128713380 hasAuthorship W3128713380A5040677118 @default.
• W3128713380 hasAuthorship W3128713380A5043460153 @default.
• W3128713380 hasAuthorship W3128713380A5062043803 @default.
• W3128713380 hasAuthorship W3128713380A5074813969 @default.
• W3128713380 hasAuthorship W3128713380A5076935419 @default.
• W3128713380 hasAuthorship W3128713380A5086960964 @default.
• W3128713380 hasAuthorship W3128713380A5091806809 @default.
• W3128713380 hasBestOaLocation W31287133801 @default.
• W3128713380 hasConcept C126322002 @default.
• W3128713380 hasConcept C141071460 @default.
• W3128713380 hasConcept C2777014857 @default.
• W3128713380 hasConcept C2777214474 @default.
• W3128713380 hasConcept C2778800853 @default.
• W3128713380 hasConcept C2780120127 @default.
• W3128713380 hasConcept C2780496750 @default.
• W3128713380 hasConcept C2780868729 @default.
• W3128713380 hasConcept C71924100 @default.
• W3128713380 hasConceptScore W3128713380C126322002 @default.
• W3128713380 hasConceptScore W3128713380C141071460 @default.
• W3128713380 hasConceptScore W3128713380C2777014857 @default.
• W3128713380 hasConceptScore W3128713380C2777214474 @default.
• W3128713380 hasConceptScore W3128713380C2778800853 @default.
• W3128713380 hasConceptScore W3128713380C2780120127 @default.
• W3128713380 hasConceptScore W3128713380C2780496750 @default.
• W3128713380 hasConceptScore W3128713380C2780868729 @default.
• W3128713380 hasConceptScore W3128713380C71924100 @default.
• W3128713380 hasIssue "1" @default.
• W3128713380 hasLocation W31287133801 @default.
• W3128713380 hasLocation W31287133802 @default.
• W3128713380 hasLocation W31287133803 @default.
• W3128713380 hasOpenAccess W3128713380 @default.
• W3128713380 hasPrimaryLocation W31287133801 @default.
• W3128713380 hasRelatedWork W1984296330 @default.
• W3128713380 hasRelatedWork W2347486323 @default.
• W3128713380 hasRelatedWork W2391842199 @default.
• W3128713380 hasRelatedWork W2416560754 @default.
• W3128713380 hasRelatedWork W2914415918 @default.
• W3128713380 hasRelatedWork W2965413776 @default.
• W3128713380 hasRelatedWork W3161799524 @default.
• W3128713380 hasRelatedWork W3165117887 @default.
• W3128713380 hasRelatedWork W4312618933 @default.
• W3128713380 hasRelatedWork W2133815194 @default.
• W3128713380 hasVolume "15" @default.
• W3128713380 isParatext "false" @default.
• W3128713380 isRetracted "false" @default.
• W3128713380 magId "3128713380" @default.
• W3128713380 workType "article" @default.